Literature DB >> 24612435

A novel mutation in the P2Y12 receptor and a function-reducing polymorphism in protease-activated receptor 1 in a patient with chronic bleeding.

Y M Patel1, M Lordkipanidzé, G C Lowe, S P Nisar, K Garner, J Stockley, M E Daly, M Mitchell, S P Watson, S K Austin, S J Mundell.   

Abstract

BACKGROUND: The study of patients with bleeding problems is a powerful approach in determining the function and regulation of important proteins in human platelets. We have identified a patient with a chronic bleeding disorder expressing a homozygous P2RY(12) mutation, predicting an arginine to cysteine (R122C) substitution in the G-protein-coupled P2Y(12) receptor. This mutation is found within the DRY motif, which is a highly conserved region in G-protein-coupled receptors (GPCRs) that is speculated to play a critical role in regulating receptor conformational states.
OBJECTIVES: To determine the functional consequences of the R122C substitution for P2Y(12) function. PATIENT/
METHODS: We performed a detailed phenotypic analysis of an index case and affected family members. An analysis of the variant R122C P2Y(12) stably expressed in cells was also performed.
RESULTS: ADP-stimulated platelet aggregation was reduced as a result of a significant impairment of P2Y(12) activity in the patient and family members. Cell surface R122C P2Y(12) expression was reduced both in cell lines and in platelets; in cell lines, this was as a consequence of agonist-independent internalization followed by subsequent receptor trafficking to lysosomes. Strikingly, members of this family also showed reduced thrombin-induced platelet activation, owing to an intronic polymorphism in the F2R gene, which encodes protease-activated receptor 1 (PAR-1), that has been shown to be associated with reduced PAR-1 receptor activity.
CONCLUSIONS: Our study is the first to demonstrate a patient with deficits in two stimulatory GPCR pathways that regulate platelet activity, further indicating that bleeding disorders constitute a complex trait.
© 2014 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  P2Y12 purinoceptor; bleeding disorder due to P2RY12 defect; blood platelets; point mutation; receptors, G-protein-coupled

Mesh:

Substances:

Year:  2014        PMID: 24612435     DOI: 10.1111/jth.12539

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  14 in total

1.  Illuminating G-Protein-Coupling Selectivity of GPCRs.

Authors:  Asuka Inoue; Francesco Raimondi; Francois Marie Ngako Kadji; Gurdeep Singh; Takayuki Kishi; Akiharu Uwamizu; Yuki Ono; Yuji Shinjo; Satoru Ishida; Nadia Arang; Kouki Kawakami; J Silvio Gutkind; Junken Aoki; Robert B Russell
Journal:  Cell       Date:  2019-05-31       Impact factor: 41.582

Review 2.  Inherited dysfunctional platelet P2Y12 receptor mutations associated with bleeding disorders.

Authors:  Anna Lecchi; Eti A Femia; Silvia Paoletta; Arnaud Dupuis; Philippe Ohlmann; Christian Gachet; Kenneth A Jacobson; Katharina Machura; Gian M Podda; Barbara Zieger; Marco Cattaneo
Journal:  Hamostaseologie       Date:  2016-08-04       Impact factor: 1.778

3.  Identification of a new dysfunctional platelet P2Y12 receptor variant associated with bleeding diathesis.

Authors:  Anna Lecchi; Cristina Razzari; Silvia Paoletta; Arnaud Dupuis; Lea Nakamura; Philippe Ohlmann; Christian Gachet; Kenneth A Jacobson; Barbara Zieger; Marco Cattaneo
Journal:  Blood       Date:  2014-11-26       Impact factor: 22.113

Review 4.  The Function and Regulation of Platelet P2Y12 Receptor.

Authors:  Xiaohua Li; Guoxing Zhang; Xia Cao
Journal:  Cardiovasc Drugs Ther       Date:  2021-07-28       Impact factor: 3.727

Review 5.  Rare platelet GPCR variants: what can we learn?

Authors:  S P Nisar; M L Jones; M R Cunningham; A D Mumford; S J Mundell
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

6.  Use of next-generation sequencing and candidate gene analysis to identify underlying defects in patients with inherited platelet function disorders.

Authors:  V C Leo; N V Morgan; D Bem; M L Jones; G C Lowe; M Lordkipanidzé; S Drake; M A Simpson; P Gissen; A Mumford; S P Watson; M E Daly
Journal:  J Thromb Haemost       Date:  2015-01-27       Impact factor: 5.824

7.  Diversity and impact of rare variants in genes encoding the platelet G protein-coupled receptors.

Authors:  Matthew L Jones; Jane E Norman; Neil V Morgan; Stuart J Mundell; Marie Lordkipanidzé; Gillian C Lowe; Martina E Daly; Michael A Simpson; Sian Drake; Steve P Watson; Andrew D Mumford
Journal:  Thromb Haemost       Date:  2015-01-08       Impact factor: 5.249

8.  Characterization of multiple platelet activation pathways in patients with bleeding as a high-throughput screening option: use of 96-well Optimul assay.

Authors:  Marie Lordkipanidzé; Gillian C Lowe; Nicholas S Kirkby; Melissa V Chan; Martina H Lundberg; Neil V Morgan; Danai Bem; Shaista P Nisar; Vincenzo C Leo; Matthew L Jones; Stuart J Mundell; Martina E Daly; Andrew D Mumford; Timothy D Warner; Steve P Watson
Journal:  Blood       Date:  2014-01-09       Impact factor: 22.113

9.  Inverse agonism at the P2Y12 receptor and ENT1 transporter blockade contribute to platelet inhibition by ticagrelor.

Authors:  Riyaad Aungraheeta; Alexandra Conibear; Mark Butler; Eamonn Kelly; Sven Nylander; Andrew Mumford; Stuart J Mundell
Journal:  Blood       Date:  2016-09-30       Impact factor: 22.113

10.  Antagonism of Protease-Activated Receptor 4 Protects Against Traumatic Brain Injury by Suppressing Neuroinflammation via Inhibition of Tab2/NF-κB Signaling.

Authors:  Jianing Luo; Xun Wu; Haixiao Liu; Wenxing Cui; Wei Guo; Kang Guo; Hao Guo; Kai Tao; Fei Li; Yingwu Shi; Dayun Feng; Hao Yan; Guodong Gao; Yan Qu
Journal:  Neurosci Bull       Date:  2020-10-27       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.